Heterocycles in natural products: Enzymes, pathways, and chemistry

从活生物体中分离出来的分子是迄今为止分离出来的一些化学上最复杂、与医学相关的化合物。这些天然产物分子对抗生素和其他药物起着至关重要的作用。我的研究小组对了解大自然如何构建天然产物感兴趣，我们的长期目标是利用这些知识开发新分子并了解新酶的功能。在本课程中，我们将使用吲哚霉素，一种独特的抗生素，具有翻译潜力，作为抗耐甲氧西林金黄色葡萄球菌（MRSA）的药物，作为阐明基础生物有机化学的起点。我的小组先前的工作确定了吲哚霉素基因簇和几种独特的酶在构建这种独特结构中的作用。这些先前的结果为阐明新的酶机制和研究从基因组挖掘中确定的相关系统奠定了基础。此外，我们现在正通过结合有机化学、酶学和基因工程技术来开发新分子。

Molecules isolated from living organisms are some of the most chemically complex and medicinally relevant compounds ever isolated. These natural product molecules play critical roles as antibiotics and other drugs. My research group is interested in understanding how nature constructs natural products, and our long-term goal is to harness this knowledge to develop new molecules and to understand how novel enzymes function. In this program, we will use indolmycin, a unique antibiotic, with translational potential as an agent against methicillin-resistant Staphylococcus aureus (MRSA), as a starting point to elucidate fundamental bioorganic chemistry. Previous work in my group identified the indolmycin gene cluster and the roles of several unique enzymes in building this unique structure. These prior results set the stage to elucidate new enzyme mechanisms and investigate related systems identified from genomic mining. Furthermore, we are now positioned to develop new molecules by combining techniques from organic chemistry, enzymology, and genetic engineering. In this program, we will pursue three related objectives: first, we will use X-ray crystallography to solve the structures of indolmycin biosynthetic enzymes. Several of the indolmycin enzymes catalyze reactions that are unprecedented, and we want to understand how they work. By generating molecular “blueprints” for these enzymes, we will understand the architecture of these proteins and set the stage for engineering them to do new reactions. Second, we will elucidate three new pathways related to indolmycin. Using bioinformatics tools, we have discovered three gene clusters that have genes related to the indolmycin genes. Our goals are to understand the enzymes encoded by these new gene clusters and to elucidate the products of these new pathways. Third, we will generate a library of indolmycin derivatives by combining techniques from chemistry and biology. This work will harness and engineer the indolmycin gene cluster to make molecules that we can test for their antibiotic activity. Overall, our work will provide fundamental insights into enzymology, biosynthesis, and bioorganic chemistry and provide sustainable access to library of new indolmycin-like molecules to enable downstream translational efforts to develop new antibiotics.